Alpha Cognition Inc. (ACOGF)
USD 5.73
(0.0%)
USD 5.73
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -9.7 Million USD | 27.91% |
| 2022 | -13.46 Million USD | -16.4% |
| 2021 | -11.56 Million USD | -103.55% |
| 2020 | -5.68 Million USD | -10.11% |
| 2019 | -5.16 Million USD | -15801.2% |
| 2018 | -32.45 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.09 Million USD | 45.4% |
| 2024 Q1 | -4.43 Million USD | -103.99% |
| 2023 Q1 | -1.97 Million USD | 41.48% |
| 2023 FY | -9.93 Million USD | 26.19% |
| 2023 Q2 | -2.7 Million USD | -37.07% |
| 2023 Q4 | -2.17 Million USD | 20.99% |
| 2023 Q3 | -2.75 Million USD | -1.55% |
| 2022 Q2 | -4.37 Million USD | -50.72% |
| 2022 Q1 | -2.9 Million USD | 31.09% |
| 2022 Q4 | -3.37 Million USD | -20.3% |
| 2022 FY | -13.46 Million USD | -16.4% |
| 2022 Q3 | -2.8 Million USD | 35.84% |
| 2021 FY | -11.56 Million USD | -103.55% |
| 2021 Q2 | -2.19 Million USD | -7.78% |
| 2021 Q1 | -2.03 Million USD | -1536.91% |
| 2021 Q4 | -4.21 Million USD | -36.68% |
| 2021 Q3 | -3.08 Million USD | -40.31% |
| 2020 Q4 | -124.53 Thousand CAD | -90.75% |
| 2020 Q3 | -65.28 Thousand USD | 0.0% |
| 2020 FY | -5.68 Million USD | -10.11% |
| 2019 Q4 | -8968.73 CAD | 8.8% |
| 2019 FY | -5.16 Million USD | -15801.2% |
| 2019 Q3 | -9834.50 USD | 0.0% |
| 2018 FY | -32.45 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HST Global, Inc. | -140.9 Thousand USD | -6787.948% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -1312.854% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -5558.928% |
| CytoDyn Inc. | -18.05 Million USD | 46.253% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 83.547% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| MultiCell Technologies, Inc. | -722.81 USD | -1342659.646% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -434.355% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -92.4% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -32303.849% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -5247.881% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 82.515% |
| SQZ Biotechnologies Company | -75.82 Million USD | 87.2% |
| Resverlogix Corp. | -12.74 Million USD | 23.872% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -2391.363% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 199.622% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -295.289% |
| Mesoblast Limited | -84.14 Million USD | 88.466% |
| GB Sciences, Inc. | -1.42 Million USD | -583.248% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -1312.854% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 45.618% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -185.041% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -45.992% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -206.337% |
| ContraFect Corporation | -56.88 Million USD | 82.939% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -252.823% |
| BioStem Technologies, Inc. | -7.77 Million USD | -24.767% |
| LadRx Corporation | -3.82 Million USD | -153.832% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 38.842% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -767.346% |
| CSL Limited | 3.7 Billion USD | 100.262% |
| Biomind Labs Inc. | -1 Million USD | -861.328% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -942.067% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 111.858% |
| Nascent Biotech, Inc. | -2.22 Million USD | -335.252% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 86.48% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 297.477% |
| GeneThera, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 374.17% |
| Adynxx, Inc. | - USD | Infinity% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -531.855% |
| Marizyme, Inc. | -34.08 Million USD | 71.527% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -16.235% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -1618.648% |
| Zenith Capital Corp. | -8.94 Million USD | -8.527% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -240.487% |
| Halberd Corporation | -75.05 Thousand USD | -12832.18% |
| Genus plc | 6.4 Million USD | 251.65% |
| Pharming Group N.V. | -4.87 Million USD | -98.904% |
| MetaStat, Inc. | - USD | Infinity% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -388.583% |
| IMV Inc. | -38.67 Million USD | 74.902% |
| Affymax, Inc. | -15.04 Million USD | 35.494% |
| SYBLEU INC | -149.18 Thousand USD | -6405.967% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -829.655% |
| Enzolytics Inc. | -2.14 Million USD | -351.675% |
| argenx SE | -425.04 Million USD | 97.717% |
| AVAX Technologies, Inc. | 6.69 Million USD | 245.014% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -592.273% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -626.777% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -159.063% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -38460.195% |
| Cell Source, Inc. | -4.32 Million USD | -124.389% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -1909.183% |
| Q BioMed Inc. | -3.44 Million USD | -181.68% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -128.991% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -672.739% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -269.382% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -113.089% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 82.345% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -234.532% |
| Rebus Holdings, Inc. | -664 Thousand USD | -1361.687% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -886.288% |
| Skye Bioscience, Inc. | -13.67 Million USD | 29.01% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -420.583% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -384.129% |
| ONE Bio Corp. | 13.68 Million USD | 170.939% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -402.202% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -762.792% |
| Agentix Corp. | -1.37 Million USD | -607.531% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -232.447% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -514.529% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -55612.077% |
| Kadimastem Ltd | -3.04 Million USD | -219.237% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -3608.306% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -2236.003% |
| NovAccess Global Inc. | -2.46 Million USD | -293.455% |
| Itoco Inc. | -919.14 Thousand USD | -955.944% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -4310.073% |
| Qrons Inc. | -643.67 Thousand USD | -1407.837% |
| Mobile Lads Corp. | -554.55 Thousand USD | -1650.176% |
| Genscript Biotech Corporation | -415.79 Million USD | 97.666% |
| International Stem Cell Corporation | -663 Thousand USD | -1363.892% |
| Bioxytran, Inc. | -3.82 Million USD | -154.064% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -18337.692% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -47616.819% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 73.238% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -499.852% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -1218.991% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -211.977% |
| Neutra Corp. | -229.48 Thousand USD | -4129.278% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 44.663% |
| PureTech Health plc | -146.19 Million USD | 93.361% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 54.839% |
| IXICO plc | -1.43 Million USD | -575.407% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -2.261% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 92.032% |
| CSL Limited | 3.81 Billion USD | 100.255% |
| Cellectis S.A. | -108.85 Million USD | 91.084% |